Benjamin Shaker - 19 Oct 2022 Form 4/A - Amendment Insider Report for agilon health, inc. (AGL)

Role
Chief Markets Officer
Signature
/s/ Timothy Bensley, as Attorney-in-Fact
Issuer symbol
AGL
Transactions as of
19 Oct 2022
Transactions value $
-$1,008,308
Form type
4/A - Amendment
Filing time
21 Oct 2022, 20:52:22 UTC
Date Of Original Report
21 Oct 2022
Previous filing
22 Jul 2022
Next filing
18 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGL Common Stock Sale -$387,917 -19,552 -42% $19.84 26,525 19 Oct 2022 Direct F1, F2, F3, F4
transaction AGL Common Stock Sale -$18,555 -900 -3.4% $20.62 25,625 19 Oct 2022 Direct F1, F3, F4, F5
transaction AGL Common Stock Sale -$570,844 -28,048 -51% $20.35 27,125 20 Oct 2022 Direct F1, F3, F4, F6
transaction AGL Common Stock Sale -$30,991 -1,500 -5.5% $20.66 25,625 20 Oct 2022 Direct F1, F3, F4, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $19.52 to $20.36, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F3 Includes restricted stock units.
F4 The total was decreased by 1,507 shares as reported in the Form 4 Amendment filed on September 29, 2022.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $20.52 to $20.75, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $19.64 to $20.63, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $20.64 to $20.71, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Remarks:

This Form 4 Amendment includes a footnote reference which was inadvertently omitted in the form filed on October 21, 2022.